Vinicius Bonato Selected Research

Ligands

11/2021

Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinicius Bonato Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2017
1	Cicatrix (Scar) 01/2023
1	Residual Neoplasm 12/2020
1	Ovarian Epithelial Carcinoma 01/2018
1	Fallopian Tube Neoplasms 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2014
1	Hyperglycemia 01/2014

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2021
1	Estrogens (Estrogen)FDA Link 01/2023
1	palbociclibIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	LigandsIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	InterferonsIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	RacivirIBA 01/2018
1	LipidsIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	GlucokinaseIBA 01/2014
1	6- (3- cyclopentyl- 2- (4- (trifluoromethyl)- 1H- imidazol- 1- yl)propanamido)nicotinic acidIBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2020
1	AT protocol 11/2021
1	Neoadjuvant Therapy 12/2020
1	Drug Therapy (Chemotherapy) 12/2020